Daré Bioscience, Inc.DARENASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
37.93%
↑ 140% above average
Average (39q)
-95.60%
Historical baseline
Range
High:288.89%
Low:-1769.51%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 37.93% |
| Q2 2025 | 10.00% |
| Q1 2025 | 23.08% |
| Q4 2024 | -18.18% |
| Q3 2024 | -135.95% |
| Q2 2024 | 288.89% |
| Q1 2024 | -17.39% |
| Q4 2023 | 36.70% |
| Q3 2023 | 10.66% |
| Q2 2023 | -7.96% |
| Q1 2023 | 51.71% |
| Q4 2022 | -138.78% |
| Q3 2022 | -1769.51% |
| Q2 2022 | 158.70% |
| Q1 2022 | 23.08% |
| Q4 2021 | 27.78% |
| Q3 2021 | 0.00% |
| Q2 2021 | -12.50% |
| Q1 2021 | 40.74% |
| Q4 2020 | -12.50% |
| Q3 2020 | 11.11% |
| Q2 2020 | -50.00% |
| Q1 2020 | -12.50% |
| Q4 2019 | 20.00% |
| Q3 2019 | 94.25% |
| Q2 2019 | -7.41% |
| Q1 2019 | -1146.15% |
| Q4 2018 | 90.58% |
| Q3 2018 | 28.13% |
| Q2 2018 | 63.64% |
| Q1 2018 | -905.71% |
| Q4 2017 | 73.48% |
| Q3 2017 | 40.00% |
| Q2 2017 | -103.70% |
| Q1 2017 | -89.47% |
| Q4 2016 | -612.50% |
| Q3 2016 | 93.95% |
| Q2 2016 | 19.80% |
| Q1 2016 | -26.60% |
| Q4 2015 | -1.30% |